Brendan Bell

Brendan Bell is currently SVP, Corporate Strategy & Development, reporting to Dynasty’s Chief Capital Officer & Head of Corporate Development, Sam Anderson. In this current role, Brendan supports Sam in managing Dynasty’s corporate development initiatives, balance sheet investments, and certain key strategic relationships. Brendan is also a member of Dynasty’s Office of Special Projects, a cross-functional department that evaluates and leads important new business initiatives and strategic partnerships.

In his prior role, Brendan was Head of Dynasty Connect, where he was responsible for the strategy and execution of Dynasty’s newest business line – an outsourced front office supporting the organic and inorganic growth efforts of advisors in the Dynasty Network. Prior to Dynasty Connect, Brendan served as Chief of Staff to the CEO, Shirl Penney, through multiple stages of Dynasty’s evolution and growth.

Prior to joining Dynasty, Brendan was a post-graduate fellow in the School of Engineering & Applied Science at Yale University, where his research focused on cancer immunotherapy. He was published for his work exploring the immunotherapeutic effects of nanoparticle drug delivery. During his time at Yale, Brendan also filed a patent for a medical device designed to prevent stroke during cardiovascular intervention. Brendan received a B.S. in Chemistry as a member of the Honors Program at Boston College.